These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38468343)

  • 1. Kynurenine in IDO1
    Ying X; Zheng X; Zhang X; Yin Y; Wang X
    J Transl Med; 2024 Mar; 22(1):267. PubMed ID: 38468343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis.
    Zhang D; Ning J; Ramprasath T; Yu C; Zheng X; Song P; Xie Z; Zou MH
    Nat Commun; 2022 Oct; 13(1):6371. PubMed ID: 36289221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-18a-5p derived from mesenchymal stem cells-extracellular vesicles inhibits ovarian cancer cell proliferation, migration, invasion, and chemotherapy resistance.
    Wang X; Jiang L; Liu Q
    J Transl Med; 2022 Jun; 20(1):258. PubMed ID: 35672774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
    Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
    Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.
    Zheng Y; Zhu K; Wang G
    Clin Exp Metastasis; 2022 Aug; 39(4):603-621. PubMed ID: 35449340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
    Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
    Front Immunol; 2022; 13():832263. PubMed ID: 35371054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis.
    Xiang Z; Li J; Song S; Wang J; Cai W; Hu W; Ji J; Zhu Z; Zang L; Yan R; Yu Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):314. PubMed ID: 31315643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer derived extracellular vesicles promote the cancer progression and angiogenesis by mediating M2 macrophages polarization.
    Tang X; Ma C; Wu Q; Yu M
    J Ovarian Res; 2024 Aug; 17(1):172. PubMed ID: 39182150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process.
    Salminen A
    Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
    Wang Y; Song J; Yu K; Nie D; Zhao C; Jiao L; Wang Z; Zhou L; Wang F; Yu Q; Zhang S; Wen Z; Wu J; Wang CY; Wang DW; Cheng J; Zhao C
    Hypertension; 2023 Oct; 80(10):2099-2111. PubMed ID: 37485661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis.
    Yin L; Wang Y
    Cancer Immunol Immunother; 2023 Mar; 72(3):743-758. PubMed ID: 36319716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis.
    Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA
    Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
    Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
    Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer.
    Mandarano M; Orecchini E; Bellezza G; Vannucci J; Ludovini V; Baglivo S; Tofanetti FR; Chiari R; Loreti E; Puma F; Sidoni A; Belladonna ML
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
    Odunsi K; Qian F; Lugade AA; Yu H; Geller MA; Fling SP; Kaiser JC; Lacroix AM; D'Amico L; Ramchurren N; Morishima C; Disis ML; Dennis L; Danaher P; Warren S; Nguyen VA; Ravi S; Tsuji T; Rosario S; Zha W; Hutson A; Liu S; Lele S; Zsiros E; McGray AJR; Chiello J; Koya R; Chodon T; Morrison CD; Putluri V; Putluri N; Mager DE; Gunawan R; Cheever MA; Battaglia S; Matsuzaki J
    Sci Transl Med; 2022 Mar; 14(636):eabg8402. PubMed ID: 35294258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATA3 Encapsulated by Tumor-Associated Macrophage-Derived Extracellular Vesicles Promotes Immune Escape and Chemotherapy Resistance of Ovarian Cancer Cells by Upregulating the CD24/Siglec-10 Axis.
    Chen C; Zhang L; Ruan Z
    Mol Pharm; 2023 Feb; 20(2):971-986. PubMed ID: 36547230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peripheral blood mononuclear cell-based in vitro model: A tool to explore indoleamine 2, 3-dioxygenase-1 (IDO1).
    Gonçalves M; Furgiuele A; Rasini E; Legnaro M; Ferrari M; Luini A; Rodrigues-Santos P; Caramelo F; Marino F; Pereira FC; Cosentino M
    Eur J Pharmacol; 2024 Apr; 968():176420. PubMed ID: 38367683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
    Grobben Y; de Man J; van Doornmalen AM; Muller M; Willemsen-Seegers N; Vu-Pham D; Mulder WR; Prinsen MBW; de Wit J; Sterrenburg JG; van Cauter F; den Ouden JE; van Altena AM; Massuger LF; Uitdehaag JCM; Buijsman RC; Zaman GJR
    Front Immunol; 2020; 11():609490. PubMed ID: 33584686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.